FTC Criticizes Gilead’s ‘Inconsistent’ Competition Claims
FTC’s Amicus Brief In HIV Drugs Case Contradicts Gilead’s Market Definition
The US Federal Trade Commission has published an amicus brief setting out its views on market definition in a case in which Gilead has been accused of anti-competitive practices regarding HIV drugs.
